Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer

被引:219
作者
Stoutjesdijk, MJ
Boetes, C
Jager, GJ
Beex, L
Bult, P
Hendriks, JHCL
Laheij, RJF
Massuger, L
van Die, LE
Wobbes, T
Barentsz, JO
机构
[1] Univ Nijmegen, Med Ctr St Radboud, Dept Radiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr St Radboud, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr St Radboud, Dept Med Technol Assessment, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Med Ctr St Radboud, Dept Gynecol, NL-6500 HB Nijmegen, Netherlands
[5] Univ Nijmegen, Med Ctr St Radboud, Dept Surg, NL-6500 HB Nijmegen, Netherlands
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 14期
关键词
D O I
10.1093/jnci/93.14.1095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although breast cancer screening is recommended to start at a younger age for women with a hereditary risk of breast cancer, the sensitivity of mammography for these women is reduced. We compared magnetic resonance imaging (MRI) with mammography to determine which is more sensitive and whether MRI could play a role in the early detection of breast cancer for these women, Methods: We constructed a retrospective cohort of all breast MRI and mammography surveillance reports made in our department from November 1994 to February 2001, All of the 179 women in the cohort had received biannual palpation in addition to annual imaging by MRI, mammography, or both. The 258 MRI images and the 262 mammograms were classified with the use of the BI-RADS (TM) (i.e., Breast Imaging Reporting and Data System) scoring system, which has five categories to indicate the level of suspicion of a lesion. Receiver operator characteristic curves were generated for MRI and mammography, and the area under each curve (AUC) was assessed for the entire cohort of 179 women and for a subset of 75 women who had received both an MRI and a mammographic examination within a 4-month period. All statistical tests were two-sided. Results: In the cohort of 179 women, we detected 13 breast cancers. Seven cancers were not revealed by mammography, but all were detected by MRI, For the entire cohort, the AUC for mammography was 0.74 (95% confidence interval [CI] = 0.68 to 0.79), and the AUC for MRI was 0.99 (95% CI = 0.98 to 1.0), For the subset of women who had both examinations, the AUC for mammography was 0.70 (95% CI = 0.60 to 0.80), and the AUC for MRI was 0.98 (95% CI = 0.95 to 1.0), Conclusion: R IRI was more accurate than mammography in annual breast cancer surveillance of women with a hereditary risk of breast cancer. Larger prospective studies to examine the role of MRI in screening programs are justified.
引用
收藏
页码:1095 / 1102
页数:8
相关论文
共 59 条
[11]   A QUICKSCORE METHOD FOR IMMUNOHISTOCHEMICAL SEMIQUANTITATION - VALIDATION FOR ESTROGEN-RECEPTOR IN BREAST CARCINOMAS [J].
DETRE, S ;
JOTTI, GS ;
DOWSETT, M .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (09) :876-878
[12]   Prospectively detected cancer in familial breast/ovarian cancer screening [J].
Dorum, A ;
Heimdal, K ;
Lovslett, K ;
Kristensen, G ;
Hansen, LJ ;
Sandvei, R ;
Schiefloe, A ;
Hagen, B ;
Himmelmann, A ;
Jerve, F ;
Shetelig, K ;
Fjaerestad, I ;
Tropé, C ;
Moller, P .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (10) :906-911
[13]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[14]  
EASTON DF, 1993, AM J HUM GENET, V52, P678
[15]  
ELSTON CW, 1987, DIAGNOSTIC HISTOPATH, P300
[16]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[17]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[18]   THE GENETICS OF BREAST AND OVARIAN-CANCER [J].
FORD, D ;
EASTON, DF .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :805-812
[19]   MRI of the breast: state of the art [J].
Friedrich, M .
EUROPEAN RADIOLOGY, 1998, 8 (05) :707-725
[20]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886